Passage Bio Inc
NASDAQ:PASG
Balance Sheet
Balance Sheet Decomposition
Passage Bio Inc
Passage Bio Inc
Balance Sheet
Passage Bio Inc
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
25
|
159
|
135
|
129
|
35
|
22
|
38
|
|
| Cash Equivalents |
25
|
159
|
135
|
129
|
35
|
22
|
38
|
|
| Short-Term Investments |
0
|
0
|
170
|
187
|
155
|
93
|
39
|
|
| Other Current Assets |
9
|
7
|
12
|
9
|
7
|
4
|
2
|
|
| Total Current Assets |
33
|
166
|
317
|
325
|
197
|
118
|
79
|
|
| PP&E Net |
0
|
1
|
3
|
24
|
42
|
32
|
23
|
|
| PP&E Gross |
0
|
1
|
0
|
24
|
42
|
32
|
23
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
3
|
5
|
7
|
10
|
|
| Other Long-Term Assets |
0
|
12
|
8
|
6
|
4
|
0
|
0
|
|
| Total Assets |
34
N/A
|
179
+433%
|
328
+84%
|
355
+8%
|
244
-31%
|
151
-38%
|
102
-32%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
1
|
5
|
9
|
4
|
1
|
1
|
|
| Accrued Liabilities |
0
|
3
|
15
|
19
|
14
|
13
|
10
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
1
|
1
|
0
|
2
|
8
|
|
| Total Current Liabilities |
0
|
4
|
21
|
30
|
18
|
16
|
19
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
2
|
1
|
2
|
7
|
24
|
23
|
22
|
|
| Total Liabilities |
3
N/A
|
4
+72%
|
23
+442%
|
36
+56%
|
42
+16%
|
39
-7%
|
41
+5%
|
|
| Equity | ||||||||
| Common Stock |
43
|
231
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
13
|
59
|
171
|
356
|
492
|
594
|
659
|
|
| Additional Paid In Capital |
1
|
2
|
476
|
675
|
695
|
706
|
720
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Equity |
31
N/A
|
174
+464%
|
305
+75%
|
319
+5%
|
201
-37%
|
111
-45%
|
61
-45%
|
|
| Total Liabilities & Equity |
34
N/A
|
179
+433%
|
328
+84%
|
355
+8%
|
244
-31%
|
151
-38%
|
102
-32%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
3
|
3
|
3
|
3
|
|